Panel: What it takes to fund advanced therapies in 2026
07 Sept 2026
Workshop Room
Investment Summit
Story-driven investing is over, what does evidence driven investing actually demand from founders?
- From narrative to proof: why scientific promise alone no longer closes rounds, and what constitutes a complete investment case today
- Data, manufacturing, regulatory strategy and commercial pathways – the non-negotiables of an investable company in 2026
- How recent market downturns have reshaped investor expectations, risk tolerance and capital deployment strategies